StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 24 Aug 2026 13:20:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Form 4 Protagenic Therapeutics, For: Aug 21 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+21++Filed+by%3A+ARMEN+GARO+H/26966833.html si-local-file:///var/storage/secattach/20260824/26966833.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+21++Filed+by%3A+ARMEN+GARO+H/26966833.html Mon, 24 Aug 2026 13:20:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 21 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+21++Filed+by%3A+ARMEN+GARO+H/26966833.html si-local-file:///var/storage/secattach/20260824/26966833.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+21++Filed+by%3A+ARMEN+GARO+H/26966833.html Mon, 24 Aug 2026 13:20:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 20 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+20++Filed+by%3A+ARMEN+GARO+H/26957544.html si-local-file:///var/storage/secattach/20260820/26957544.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+20++Filed+by%3A+ARMEN+GARO+H/26957544.html Thu, 20 Aug 2026 20:21:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 20 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+20++Filed+by%3A+ARMEN+GARO+H/26957544.html si-local-file:///var/storage/secattach/20260820/26957544.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+20++Filed+by%3A+ARMEN+GARO+H/26957544.html Thu, 20 Aug 2026 20:21:00 -0400 O.03095092 PTIX Form 8-K Protagenic Therapeutics, For: Aug 20 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Protagenic+Therapeutics%2C++For%3A+Aug+20/26954828.html si-local-file:///var/storage/secattach/20260820/26954828.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Protagenic+Therapeutics%2C++For%3A+Aug+20/26954828.html Thu, 20 Aug 2026 11:26:00 -0400 O.03095092 PTIX Form 8-K Protagenic Therapeutics, For: Aug 20 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Protagenic+Therapeutics%2C++For%3A+Aug+20/26954828.html si-local-file:///var/storage/secattach/20260820/26954828.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Protagenic+Therapeutics%2C++For%3A+Aug+20/26954828.html Thu, 20 Aug 2026 11:26:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 19 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+19++Filed+by%3A+ARMEN+GARO+H/26954048.html si-local-file:///var/storage/secattach/20260820/26954048.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+19++Filed+by%3A+ARMEN+GARO+H/26954048.html Thu, 20 Aug 2026 09:24:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 19 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+19++Filed+by%3A+ARMEN+GARO+H/26954048.html si-local-file:///var/storage/secattach/20260820/26954048.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+19++Filed+by%3A+ARMEN+GARO+H/26954048.html Thu, 20 Aug 2026 09:24:00 -0400 O.03095092 PTIX FDA clears path for Protagenic's PT00114 anxiety drug IND submission http://www.streetinsider.com/Corporate+News/FDA+clears+path+for+Protagenic%27s+PT00114+anxiety+drug+IND+submission/26953544.html <p>Protagenic Therapeutics, Inc. (OTCQB: PTIX) announced it has received written feedback from the U.S. Food and Drug Administration following a Type B pre-Investigational New Drug meeting request for PT00114, its investigational neuropeptide candidate for the treatment of generalized anxiety disorder (GAD).</p><p>The FDA identified no clinical hold issues and raised no objection to the company's planned three-part Phase 1 program design, dose-escalation approach, or safety review governance. The agency also indicated that the company's proposed chemistry, manufacturing, and controls package, along with its nonclinical and potency and comparability packages, appear reasonable to support an IND submission.</p><p>Protagenic plans to submit the IND http://www.streetinsider.com/Corporate+News/FDA+clears+path+for+Protagenic%27s+PT00114+anxiety+drug+IND+submission/26953544.html Thu, 20 Aug 2026 08:34:09 -0400 PTIX FDA clears path for Protagenic's PT00114 anxiety drug IND submission http://www.streetinsider.com/FDA/FDA+clears+path+for+Protagenic%27s+PT00114+anxiety+drug+IND+submission/26953544.html <p>Protagenic Therapeutics, Inc. (OTCQB: PTIX) announced it has received written feedback from the U.S. Food and Drug Administration following a Type B pre-Investigational New Drug meeting request for PT00114, its investigational neuropeptide candidate for the treatment of generalized anxiety disorder (GAD).</p><p>The FDA identified no clinical hold issues and raised no objection to the company's planned three-part Phase 1 program design, dose-escalation approach, or safety review governance. The agency also indicated that the company's proposed chemistry, manufacturing, and controls package, along with its nonclinical and potency and comparability packages, appear reasonable to support an IND submission.</p><p>Protagenic plans to submit the IND http://www.streetinsider.com/FDA/FDA+clears+path+for+Protagenic%27s+PT00114+anxiety+drug+IND+submission/26953544.html Thu, 20 Aug 2026 08:34:09 -0400 PTIX Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder http://www.streetinsider.com/Press+Releases/Protagenic+Therapeutics+Receives+FDA+Pre-IND+Feedback+Supporting+New+IND+for+PT00114+in+Generalized+Anxiety+Disorder/26953486.html <p><i><strong>FDA raises no objection to the Company's planned Phase 1 program design, dose-escalation approach, or CMC and nonclinical packages; IND submission remains on track for the fourth quarter of 2026</strong></i></p> <p><strong id="dateline">NEW YORK, NY / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / August 20, 2026 / </strong>Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing novel peptide-based treatments for stress-related neuropsychiatric disorders, today announced that it has received written responses from the U.S. Food and Drug Administration (FDA) to its Type B pre-Investigational New Drug (pre-IND) meeting request for PT00114, the Company's leading investigational neuropeptide product candidate, http://www.streetinsider.com/Press+Releases/Protagenic+Therapeutics+Receives+FDA+Pre-IND+Feedback+Supporting+New+IND+for+PT00114+in+Generalized+Anxiety+Disorder/26953486.html Thu, 20 Aug 2026 08:30:00 -0400 PTIX Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder http://www.streetinsider.com/ACCESS+Newswire/Protagenic+Therapeutics+Receives+FDA+Pre-IND+Feedback+Supporting+New+IND+for+PT00114+in+Generalized+Anxiety+Disorder/26953486.html <p><i><strong>FDA raises no objection to the Company's planned Phase 1 program design, dose-escalation approach, or CMC and nonclinical packages; IND submission remains on track for the fourth quarter of 2026</strong></i></p> <p><strong id="dateline">NEW YORK, NY / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / August 20, 2026 / </strong>Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing novel peptide-based treatments for stress-related neuropsychiatric disorders, today announced that it has received written responses from the U.S. Food and Drug Administration (FDA) to its Type B pre-Investigational New Drug (pre-IND) meeting request for PT00114, the Company's leading investigational neuropeptide product candidate, http://www.streetinsider.com/ACCESS+Newswire/Protagenic+Therapeutics+Receives+FDA+Pre-IND+Feedback+Supporting+New+IND+for+PT00114+in+Generalized+Anxiety+Disorder/26953486.html Thu, 20 Aug 2026 08:30:00 -0400 PTIX Form 10-Q Protagenic Therapeutics, For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Protagenic+Therapeutics%2C++For%3A+Jun+30/26950441.html si-local-file:///var/storage/secattach/20260819/26950441.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Protagenic+Therapeutics%2C++For%3A+Jun+30/26950441.html Wed, 19 Aug 2026 16:29:00 -0400 O.03095092 PTIX Form 10-Q Protagenic Therapeutics, For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Protagenic+Therapeutics%2C++For%3A+Jun+30/26950441.html si-local-file:///var/storage/secattach/20260819/26950441.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Protagenic+Therapeutics%2C++For%3A+Jun+30/26950441.html Wed, 19 Aug 2026 16:29:00 -0400 O.03095092 PTIX Form NT 10-Q Protagenic Therapeutics, For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Protagenic+Therapeutics%2C++For%3A+Jun+30/26929452.html si-local-file:///var/storage/secattach/20260814/26929452.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Protagenic+Therapeutics%2C++For%3A+Jun+30/26929452.html Fri, 14 Aug 2026 15:20:00 -0400 O.03095092 PTIX Form NT 10-Q Protagenic Therapeutics, For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Protagenic+Therapeutics%2C++For%3A+Jun+30/26929452.html si-local-file:///var/storage/secattach/20260814/26929452.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++Protagenic+Therapeutics%2C++For%3A+Jun+30/26929452.html Fri, 14 Aug 2026 15:20:00 -0400 O.03095092 PTIX Form 10-K Protagenic Therapeutics, For: Mar 31 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Protagenic+Therapeutics%2C++For%3A+Mar+31/26929447.html si-local-file:///var/storage/secattach/20260814/26929447.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Protagenic+Therapeutics%2C++For%3A+Mar+31/26929447.html Fri, 14 Aug 2026 15:19:00 -0400 O.03095092 PTIX Form 10-K Protagenic Therapeutics, For: Mar 31 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Protagenic+Therapeutics%2C++For%3A+Mar+31/26929447.html si-local-file:///var/storage/secattach/20260814/26929447.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Protagenic+Therapeutics%2C++For%3A+Mar+31/26929447.html Fri, 14 Aug 2026 15:19:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 11 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+11++Filed+by%3A+ARMEN+GARO+H/26914710.html si-local-file:///var/storage/secattach/20260812/26914710.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+11++Filed+by%3A+ARMEN+GARO+H/26914710.html Wed, 12 Aug 2026 18:52:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 11 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+11++Filed+by%3A+ARMEN+GARO+H/26914710.html si-local-file:///var/storage/secattach/20260812/26914710.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+11++Filed+by%3A+ARMEN+GARO+H/26914710.html Wed, 12 Aug 2026 18:52:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 06 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+06++Filed+by%3A+ARMEN+GARO+H/26895803.html si-local-file:///var/storage/secattach/20260810/26895803.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+06++Filed+by%3A+ARMEN+GARO+H/26895803.html Mon, 10 Aug 2026 10:18:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 06 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+06++Filed+by%3A+ARMEN+GARO+H/26895803.html si-local-file:///var/storage/secattach/20260810/26895803.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+06++Filed+by%3A+ARMEN+GARO+H/26895803.html Mon, 10 Aug 2026 10:18:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 05 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+05++Filed+by%3A+ARMEN+GARO+H/26886078.html si-local-file:///var/storage/secattach/20260806/26886078.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+05++Filed+by%3A+ARMEN+GARO+H/26886078.html Thu, 06 Aug 2026 20:30:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Aug 05 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+05++Filed+by%3A+ARMEN+GARO+H/26886078.html si-local-file:///var/storage/secattach/20260806/26886078.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Aug+05++Filed+by%3A+ARMEN+GARO+H/26886078.html Thu, 06 Aug 2026 20:30:00 -0400 O.03095092 PTIX Form 4 Protagenic Therapeutics, For: Jul 30 Filed by: ARMEN GARO H http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Jul+30++Filed+by%3A+ARMEN+GARO+H/26859497.html si-local-file:///var/storage/secattach/20260803/26859497.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Protagenic+Therapeutics%2C++For%3A+Jul+30++Filed+by%3A+ARMEN+GARO+H/26859497.html Mon, 03 Aug 2026 17:29:00 -0400 O.03095092 PTIX